APO Research
Talk to an analyst

APO RESEARCH · REPORT

OAB Treatment

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global OAB Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

29 December 2025180 pages

Choose your research edition.

Industry ResearchOAB Treatment Industry Research Report 2026112 pages · $2,950 USDIndustry Growth & TrendsGlobal OAB Treatment Industry Growth and Trends Forecast to 203288 pages · $3,450 USDMarket StructureGlobal OAB Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal OAB Treatment Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal OAB Treatment Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global OAB Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for OAB Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for OAB Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for OAB Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for OAB Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of OAB Treatment include Astellas Pharma, Kyorin Pharmaceutical, AbbVie, Pfizer, Johnson & Johnson and Teva, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global OAB Treatment market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of OAB Treatment and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents OAB Treatment revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the OAB Treatment market size, projected growth trends, production technologies, key applications, and end-use industries.

OAB Treatment Segment by Company

Astellas Pharma

Kyorin Pharmaceutical

AbbVie

Pfizer

Johnson & Johnson

Teva

OAB Treatment Segment by Type

Botox

Mirabegron

Anticholinergics

Others

OAB Treatment Segment by Application

Idiopathic Overactive Bladder

Neurogenic Overactive Bladder

OAB Treatment Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global OAB Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of OAB Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of OAB Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of OAB Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global OAB Treatment industry.

Chapter 3: Detailed analysis of OAB Treatment companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, OAB Treatmentrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global OAB Treatment Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Botox Table 3. Key Players of Mirabegron Table 4. Key Players of Anticholinergics Table 3. Key Players of Others Table 4. Global OAB Treatment Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Idiopathic Overactive Bladder Table 6. Key Players of Neurogenic Overactive Bladder Table 7. Global OAB Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 8. Global OAB Treatment Market Size by Region (2021-2026) & (US$ Million) Table 9. Global OAB Treatment Market Share by Region (2021-2026) Table 10. Global OAB Treatment Market Size by Region (2027-2032) & (US$ Million) Table 11. Global OAB Treatment Market Share by Region (2027-2032) Table 12. OAB Treatment Industry Trends Table 13. OAB Treatment Industry Drivers Table 14. OAB Treatment Industry Opportunities and Challenges Table 15. OAB Treatment Industry Restraints Table 16. Global OAB Treatment Revenue by Company (US$ Million) & (2021-2026) Table 17. Global OAB Treatment Revenue Market Share by Company (2021-2026) Table 18. Global OAB Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 19. Global OAB Treatment Key Company Head Office and Area Served Table 20. Global OAB Treatment Company, Product Type & Application Table 21. Global OAB Treatment Company Establishment Date Table 22. Global Company Market Concentration Ratio (CR5 and HHI) Table 23. Global OAB Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 24. Global OAB Treatment Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global OAB Treatment Market Size by Type (2021-2026) & (US$ Million) Table 26. Global OAB Treatment Market Size by Type (2027-2032) & (US$ Million) Table 27. Global OAB Treatment Revenue Market Share by Type (2021-2026) Table 28. Global OAB Treatment Revenue Market Share by Type (2027-2032) Table 29. Global OAB Treatment Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global OAB Treatment Market Size by Application (2021-2026) & (US$ Million) Table 31. Global OAB Treatment Market Size by Application (2027-2032) & (US$ Million) Table 32. Global OAB Treatment Revenue Market Share by Application (2021-2026) Table 33. Global OAB Treatment Revenue Market Share by Application (2027-2032) Table 34. Astellas Pharma Company Information Table 35. Astellas Pharma Business Overview Table 36. Astellas Pharma OAB Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Astellas Pharma OAB Treatment Product Portfolio Table 38. Astellas Pharma Recent Development Table 39. Kyorin Pharmaceutical Company Information Table 40. Kyorin Pharmaceutical Business Overview Table 41. Kyorin Pharmaceutical OAB Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Kyorin Pharmaceutical OAB Treatment Product Portfolio Table 43. Kyorin Pharmaceutical Recent Development Table 44. AbbVie Company Information Table 45. AbbVie Business Overview Table 46. AbbVie OAB Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. AbbVie OAB Treatment Product Portfolio Table 48. AbbVie Recent Development Table 49. Pfizer Company Information Table 50. Pfizer Business Overview Table 51. Pfizer OAB Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Pfizer OAB Treatment Product Portfolio Table 53. Pfizer Recent Development Table 54. Johnson & Johnson Company Information Table 55. Johnson & Johnson Business Overview Table 56. Johnson & Johnson OAB Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Johnson & Johnson OAB Treatment Product Portfolio Table 58. Johnson & Johnson Recent Development Table 59. Teva Company Information Table 60. Teva Business Overview Table 61. Teva OAB Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Teva OAB Treatment Product Portfolio Table 63. Teva Recent Development Table 64. North America OAB Treatment Market Size by Type (2021-2026) & (US$ Million) Table 65. North America OAB Treatment Market Size by Type (2027-2032) & (US$ Million) Table 66. North America OAB Treatment Market Size by Application (2021-2026) & (US$ Million) Table 67. North America OAB Treatment Market Size by Application (2027-2032) & (US$ Million) Table 68. North America OAB Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 69. North America OAB Treatment Market Size by Country (2021-2026) Table 70. North America OAB Treatment Market Size by Country (2027-2032) Table 71. Europe OAB Treatment Market Size by Type (2021-2026) & (US$ Million) Table 72. Europe OAB Treatment Market Size by Type (2027-2032) & (US$ Million) Table 73. Europe OAB Treatment Market Size by Application (2021-2026) & (US$ Million) Table 74. Europe OAB Treatment Market Size by Application (2027-2032) & (US$ Million) Table 75. Europe OAB Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 76. Europe OAB Treatment Market Size by Country (2021-2026) Table 77. Europe OAB Treatment Market Size by Country (2027-2032) Table 78. China OAB Treatment Market Size by Type (2021-2026) & (US$ Million) Table 79. China OAB Treatment Market Size by Type (2027-2032) & (US$ Million) Table 80. China OAB Treatment Market Size by Application (2021-2026) & (US$ Million) Table 81. China OAB Treatment Market Size by Application (2027-2032) & (US$ Million) Table 82. Asia OAB Treatment Market Size by Type (2021-2026) & (US$ Million) Table 83. Asia OAB Treatment Market Size by Type (2027-2032) & (US$ Million) Table 84. Asia OAB Treatment Market Size by Application (2021-2026) & (US$ Million) Table 85. Asia OAB Treatment Market Size by Application (2027-2032) & (US$ Million) Table 86. Asia OAB Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 87. Asia OAB Treatment Market Size by Country (2021-2026) Table 88. Asia OAB Treatment Market Size by Country (2027-2032) Table 89. South America, Middle East & Africa OAB Treatment Market Size by Type (2021-2026) & (US$ Million) Table 90. South America, Middle East & Africa OAB Treatment Market Size by Type (2027-2032) & (US$ Million) Table 91. South America, Middle East & Africa OAB Treatment Market Size by Application (2021-2026) & (US$ Million) Table 92. South America, Middle East & Africa OAB Treatment Market Size by Application (2027-2032) & (US$ Million) Table 93. South America, Middle East & Africa OAB Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 94. South America, Middle East & Africa OAB Treatment Market Size by Country (2021-2026) Table 95. South America, Middle East & Africa OAB Treatment Market Size by Country (2027-2032) Table 96. Research Programs/Design for This Report Table 97. Authors List of This Report Table 98. Secondary Sources Table 99. Primary Sources List of Figures Figure 1. OAB Treatment Product Image Figure 2. Global OAB Treatment Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global OAB Treatment Market Share by Type: 2025 VS 2032 Figure 4. Botox Image Figure 5. Mirabegron Image Figure 6. Anticholinergics Image Figure 7. Others Image Figure 8. Global OAB Treatment Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global OAB Treatment Market Share by Application: 2025 VS 2032 Figure 10. Idiopathic Overactive Bladder Image Figure 11. Neurogenic Overactive Bladder Image Figure 12. Global OAB Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global OAB Treatment Market Size (2021-2032) & (US$ Million) Figure 14. Global OAB Treatment Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global OAB Treatment Market Share by Players in 2025 Figure 17. Global Top 5 and 10 OAB Treatment Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global OAB Treatment Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global OAB Treatment Revenue Market Share by Type (2021-2032) Figure 21. Global OAB Treatment Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global OAB Treatment Revenue Market Share by Application (2021-2032) Figure 23. North America OAB Treatment Market Size (2021-2032) & (US$ Million) Figure 24. North America OAB Treatment Market Share by Type (2021-2032) Figure 25. North America OAB Treatment Market Share by Application (2021-2032) Figure 26. North America OAB Treatment Market Share by Country (2021-2032) Figure 27. United States OAB Treatment Market Size (2021-2032) & (US$ Million) Figure 28. Canada OAB Treatment Market Size (2021-2032) & (US$ Million) Figure 29. Mexico OAB Treatment Market Size (2021-2032) & (US$ Million) Figure 30. Europe OAB Treatment Market Size (2021-2032) & (US$ Million) Figure 31. Europe OAB Treatment Market Share by Type (2021-2032) Figure 32. Europe OAB Treatment Market Share by Application (2021-2032) Figure 33. Europe OAB Treatment Market Share by Country (2021-2032) Figure 34. Germany OAB Treatment Market Size (2021-2032) & (US$ Million) Figure 35. France OAB Treatment Market Size (2021-2032) & (US$ Million) Figure 36. U.K. OAB Treatment Market Size (2021-2032) & (US$ Million) Figure 37. Italy OAB Treatment Market Size (2021-2032) & (US$ Million) Figure 38. Russia OAB Treatment Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries OAB Treatment Market Size (2021-2032) & (US$ Million) Figure 40. China OAB Treatment Market Size (2021-2032) & (US$ Million) Figure 41. China OAB Treatment Market Share by Type (2021-2032) Figure 42. China OAB Treatment Market Share by Application (2021-2032) Figure 43. Asia OAB Treatment Market Size (2021-2032) & (US$ Million) Figure 44. Asia OAB Treatment Market Share by Type (2021-2032) Figure 45. Asia OAB Treatment Market Share by Application (2021-2032) Figure 46. Asia OAB Treatment Market Share by Country (2021-2032) Figure 47. Japan OAB Treatment Market Size (2021-2032) & (US$ Million) Figure 48. South Korea OAB Treatment Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan OAB Treatment Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia OAB Treatment Market Size (2021-2032) & (US$ Million) Figure 51. India OAB Treatment Market Size (2021-2032) & (US$ Million) Figure 52. Australia OAB Treatment Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa OAB Treatment Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa OAB Treatment Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa OAB Treatment Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa OAB Treatment Market Share by Country (2021-2032) Figure 57. Brazil OAB Treatment Market Size (2021-2032) & (US$ Million) Figure 58. South Africa OAB Treatment Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia OAB Treatment Market Size (2021-2032) & (US$ Million) Figure 60. Turkey OAB Treatment Market Size (2021-2032) & (US$ Million) Figure 61. Argentina OAB Treatment Market Size (2021-2032) & (US$ Million) Figure 62. UAE OAB Treatment Market Size (2021-2032) & (US$ Million) Figure 63. Egypt OAB Treatment Market Size (2021-2032) & (US$ Million) Figure 64. Chile OAB Treatment Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • Botox
  • Mirabegron
  • Anticholinergics
  • Others
Applications
  • Idiopathic Overactive Bladder
  • Neurogenic Overactive Bladder
Companies covered
  • Astellas Pharma
  • Kyorin Pharmaceutical
  • AbbVie
  • Pfizer
  • Johnson & Johnson
  • Teva

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global OAB Treatment Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Botox
  5. 1.2.3 Mirabegron
  6. 1.2.4 Anticholinergics
  7. 1.2.5 Others
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global OAB Treatment Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Idiopathic Overactive Bladder
  11. 1.3.3 Neurogenic Overactive Bladder
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global OAB Treatment Growth Trends by Region
  14. 1.5.1 Global OAB Treatment Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 OAB Treatment Market Size by Region (2021-2026)
  16. 1.5.3 OAB Treatment Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global OAB Treatment Market Dynamics
  1. 2.1 OAB Treatment Industry Trends
  2. 2.2 OAB Treatment Industry Drivers
  3. 2.3 OAB Treatment Industry Opportunities and Challenges
  4. 2.4 OAB Treatment Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global OAB Treatment Revenue by Company (2021-2026)
  2. 3.2 Global OAB Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global OAB Treatment Key Company Head office and Area Served
  4. 3.4 Global OAB Treatment Company, Product Type & Application
  5. 3.5 Global OAB Treatment Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global OAB Treatment Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 OAB Treatment Players Market Share by Revenue in 2025
  9. 3.6.3 2025 OAB Treatment Tier 1, Tier 2, and Tier 3
4 OAB Treatment Market by Type
  1. 4.1 Global OAB Treatment Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global OAB Treatment Market Size by Type (2021-2032)
  3. 4.3 Global OAB Treatment Market Size Share by Type (2021-2032)
5 OAB Treatment Market by Application
  1. 5.1 Global OAB Treatment Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global OAB Treatment Market Size by Application (2021-2032)
  3. 5.3 Global OAB Treatment Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Astellas Pharma
  2. 6.1.1 Astellas Pharma Company Information
  3. 6.1.2 Astellas Pharma Business Overview
  4. 6.1.3 Astellas Pharma OAB Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Astellas Pharma OAB Treatment Product Portfolio
  6. 6.1.5 Astellas Pharma Recent Developments
  7. 6.2 Kyorin Pharmaceutical
  8. 6.2.1 Kyorin Pharmaceutical Company Information
  9. 6.2.2 Kyorin Pharmaceutical Business Overview
  10. 6.2.3 Kyorin Pharmaceutical OAB Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Kyorin Pharmaceutical OAB Treatment Product Portfolio
  12. 6.2.5 Kyorin Pharmaceutical Recent Developments
  13. 6.3 AbbVie
  14. 6.3.1 AbbVie Company Information
  15. 6.3.2 AbbVie Business Overview
  16. 6.3.3 AbbVie OAB Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 AbbVie OAB Treatment Product Portfolio
  18. 6.3.5 AbbVie Recent Developments
  19. 6.4 Pfizer
  20. 6.4.1 Pfizer Company Information
  21. 6.4.2 Pfizer Business Overview
  22. 6.4.3 Pfizer OAB Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Pfizer OAB Treatment Product Portfolio
  24. 6.4.5 Pfizer Recent Developments
  25. 6.5 Johnson & Johnson
  26. 6.5.1 Johnson & Johnson Company Information
  27. 6.5.2 Johnson & Johnson Business Overview
  28. 6.5.3 Johnson & Johnson OAB Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Johnson & Johnson OAB Treatment Product Portfolio
  30. 6.5.5 Johnson & Johnson Recent Developments
  31. 6.6 Teva
  32. 6.6.1 Teva Company Information
  33. 6.6.2 Teva Business Overview
  34. 6.6.3 Teva OAB Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Teva OAB Treatment Product Portfolio
  36. 6.6.5 Teva Recent Developments
7 North America
  1. 7.1 North America OAB Treatment Market Size (2021-2032)
  2. 7.2 North America OAB Treatment Market Size by Type
  3. 7.2.1 North America OAB Treatment Market Size by Type (2021-2026)
  4. 7.2.2 North America OAB Treatment Market Size by Type (2027-2032)
  5. 7.2.3 North America OAB Treatment Market Share by Type (2021-2032)
  6. 7.3 North America OAB Treatment Market Size by Application
  7. 7.3.1 North America OAB Treatment Market Size by Application (2021-2026)
  8. 7.3.2 North America OAB Treatment Market Size by Application (2027-2032)
  9. 7.3.3 North America OAB Treatment Market Share by Application (2021-2032)
  10. 7.4 North America OAB Treatment Market Size by Country
  11. 7.4.1 North America OAB Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America OAB Treatment Market Size by Country (2021-2026)
  13. 7.4.3 North America OAB Treatment Market Size by Country (2027-2032)
  14. 7.4.4 North America OAB Treatment Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe OAB Treatment Market Size (2021-2032)
  2. 8.2 Europe OAB Treatment Market Size by Type
  3. 8.2.1 Europe OAB Treatment Market Size by Type (2021-2026)
  4. 8.2.2 Europe OAB Treatment Market Size by Type (2027-2032)
  5. 8.2.3 Europe OAB Treatment Market Share by Type (2021-2032)
  6. 8.3 Europe OAB Treatment Market Size by Application
  7. 8.3.1 Europe OAB Treatment Market Size by Application (2021-2026)
  8. 8.3.2 Europe OAB Treatment Market Size by Application (2027-2032)
  9. 8.3.3 Europe OAB Treatment Market Share by Application (2021-2032)
  10. 8.4 Europe OAB Treatment Market Size by Country
  11. 8.4.1 Europe OAB Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe OAB Treatment Market Size by Country (2021-2026)
  13. 8.4.3 Europe OAB Treatment Market Size by Country (2027-2032)
  14. 8.4.4 Europe OAB Treatment Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China OAB Treatment Market Size (2021-2032)
  2. 9.2 China OAB Treatment Market Size by Type
  3. 9.2.1 China OAB Treatment Market Size by Type (2021-2026)
  4. 9.2.2 China OAB Treatment Market Size by Type (2027-2032)
  5. 9.2.3 China OAB Treatment Market Share by Type (2021-2032)
  6. 9.3 China OAB Treatment Market Size by Application
  7. 9.3.1 China OAB Treatment Market Size by Application (2021-2026)
  8. 9.3.2 China OAB Treatment Market Size by Application (2027-2032)
  9. 9.3.3 China OAB Treatment Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia OAB Treatment Market Size (2021-2032)
  2. 10.2 Asia OAB Treatment Market Size by Type
  3. 10.2.1 Asia OAB Treatment Market Size by Type (2021-2026)
  4. 10.2.2 Asia OAB Treatment Market Size by Type (2027-2032)
  5. 10.2.3 Asia OAB Treatment Market Share by Type (2021-2032)
  6. 10.3 Asia OAB Treatment Market Size by Application
  7. 10.3.1 Asia OAB Treatment Market Size by Application (2021-2026)
  8. 10.3.2 Asia OAB Treatment Market Size by Application (2027-2032)
  9. 10.3.3 Asia OAB Treatment Market Share by Application (2021-2032)
  10. 10.4 Asia OAB Treatment Market Size by Country
  11. 10.4.1 Asia OAB Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia OAB Treatment Market Size by Country (2021-2026)
  13. 10.4.3 Asia OAB Treatment Market Size by Country (2027-2032)
  14. 10.4.4 Asia OAB Treatment Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa OAB Treatment Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa OAB Treatment Market Size by Type
  3. 11.2.1 South America, Middle East & Africa OAB Treatment Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa OAB Treatment Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa OAB Treatment Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa OAB Treatment Market Size by Application
  7. 11.3.1 South America, Middle East & Africa OAB Treatment Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa OAB Treatment Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa OAB Treatment Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa OAB Treatment Market Size by Country
  11. 11.4.1 South America, Middle East & Africa OAB Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa OAB Treatment Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa OAB Treatment Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa OAB Treatment Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst